Samsara Bio Capital, LLC Bio N Tech Se Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $496,820 - $750,733	-4,031 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $374,137 - $626,072	-1,727 Reduced 29.99%	4,031 $1.04 Million
Q2 2021 Aug 17, 2021	SELL	$113.32 - $241.49 $570,792 - $1.22 Million	-5,037 Reduced 46.66%	5,758 $1.29 Million
Q4 2020 Feb 17, 2021	SELL	$72.71 - $129.54 $138,512 - $246,773	-1,905 Reduced 15.0%	10,795 $880,000
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $734,187 - $1.32 Million	12,700 New	12,700 $879,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.